Latest Articles
Organon's non-hormonal endometriosis hope dashed - FirstWord Pharma
Organon's non-hormonal endometriosis hope dashed FirstWord Pharma
Published: July 2, 2025, 3:25 p.m.
Organon drug for endometriosis falls short in mid-stage study - BioPharma Dive
Organon drug for endometriosis falls short in mid-stage study BioPharma Dive
Published: July 2, 2025, 2:33 p.m.
When Period Pain Is More Than Normal: Ugandan Women Battle Endometriosis and Infertility - Nilepost News
When Period Pain Is More Than Normal: Ugandan Women Battle Endometriosis and Infertility Nilepost News
Published: July 2, 2025, 2:27 p.m.
When Period Pain Is More Than Normal: Ugandan Women Battle Endometriosis and Infertility - nilepost.co.ug
When Period Pain Is More Than Normal: Ugandan Women Battle Endometriosis and Infertility nilepost.co.ug
Published: July 2, 2025, 2:27 p.m.
Sun Pharma Gets CDSCO Panel Go-Ahead to Manufacture, Market Relugolix, Estradiol, Norethindrone Acetate... - Medical Dialogues
Sun Pharma Gets CDSCO Panel Go-Ahead to Manufacture, Market Relugolix, Estradiol, Norethindrone Acetate... Medical Dialogues
Published: July 2, 2025, 11:31 a.m.
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country - Express Pharma
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country Express Pharma
Published: July 2, 2025, 7 a.m.
AstraZeneca Pharma India gets CDSCO nod for expanded use of Imfinzi in Endometrial Cancer - Medical Dialogues
AstraZeneca Pharma India gets CDSCO nod for expanded use of Imfinzi in Endometrial Cancer Medical Dialogues
Published: July 2, 2025, 6:31 a.m.
AstraZeneca Pharma India receives permission to import Durvalumab Solution - Indian Pharma Post
AstraZeneca Pharma India receives permission to import Durvalumab Solution Indian Pharma Post
Published: July 2, 2025, 5:11 a.m.
AstraZeneca Pharma gets CDSCO approval to import Durvalumab Solution - Business Standard
AstraZeneca Pharma gets CDSCO approval to import Durvalumab Solution Business Standard
Published: July 2, 2025, 4:56 a.m.
AstraZeneca's India Arm Receives Nod For Imfinzi Indication To Treat Endometrial Cancer - Republic World
AstraZeneca's India Arm Receives Nod For Imfinzi Indication To Treat Endometrial Cancer Republic World
Published: July 1, 2025, 2:59 p.m.
Link copied to clipboard!